Prevalence of extended spectrum-lactamase-producing clinical isolates of Klebsiella pneumoniae in intensive care unit patients of a tertiary care hospital

Annals of Tropical Medicine and Public Health

Volumn 4, Issue 2, 2011, Pages 96-98

  Harakuni, Sheetal ^a   Karadesai, S G ^a   Mutnal, M B ^a   Metgud, S C ^a  

^a JAWAHARLAL NEHRU MEDICAL COLLEGE   (India)

Author keywords

Extended spectrum lactamases; Intensive Care Unit; Klebsiella pneumoniae

Indexed keywords

AMIKACIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE;

ARTICLE; BACTERIUM ISOLATE; BLOOD SAMPLING; DISK DIFFUSION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; TERTIARY HEALTH CARE;

EID: 80054829692     PISSN: 17556783     EISSN: 09746005     Source Type: Journal    
DOI: 10.4103/1755-6783.85760     Document Type: Article

References (15)

1. Villa L, Pezzella C, Tosini F, Visca P, Petrucca A, Carattoli A. Multiple-antibiotic resistance mediated by structurally related Incl/M plasmids carrying an extended-spectrum beta-lactamase gene class 1 interon. Antimicrob Agents Chemother 2000;44:2911-4.
2. Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. Epidemiological investigation of fluroquinilone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2001;33:1288-94. (Pubitemid 32955176)
3. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods and pathogenicity factors. Clin Microbiol Rev 1998;11:589-603. (Pubitemid 28497563)
4. Subha A, Ananthan S, Alavandi SV. Extended spectrum beta lactamase production and multidrug resistance in Klebsiella species isolated from children under five with intestinal and extra intestinal infections. Indian J Med Res 2001;113:181-5. (Pubitemid 32916249)
5. Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ, et al. Characterisation of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods. J Clin Microbiol 2001;39:2864-72. (Pubitemid 32744003)
6. Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK. Prevalence of extended-spectrum beta-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. J Med Microbiol 2003;52:421-5. (Pubitemid 36589169)
7. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, et al. International prospective study of Klebsiella pneumoniae bacteremia: Implications of extended-spectrum b-lactamase production in nosocomial infections. Ann Intern Med 2004;140:26-32. (Pubitemid 38055918)
8. Crichton PB. Enterobacteriaceae: Escherichia, Klebsiella, Proteus and other genera. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Practical Medical Microbiology. 14 th Ed. Mackie and McCartney. Amsterdam: Elsevier; 1996: P. 361-84.
9. Wayne PA. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests. Approved standards. NCCLS document M2-A7. 7 th ed. vol 20. 2000.
10. Nolte FS, Metchock B. Mycobacte rium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolkia RH, editors. Manual of Clinical microbiological laboratory. 6 th ed. Washington DC: American society for Microbiology Press; 1999. p. 400-37.
11. Peña C, Pujol M, Ardanuy C, Ricart A, Pallares R, Liñares J, et al. Epidemiology and Successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum b-lactamases. Antimicrob Agents Chemother 1998;42:53-8. (Pubitemid 28053326)
12. Jacoby GA, Sutton L. Properties of plasmids responsible for production of extended-spectrum b-lactamases. Antimicrob Agents Chemother 1991;35:164-9.
13. Jacoby GA, Medeiros AA. More extended-spectrum b-lactamases. Antimicrob Agents Chemother 1991;35:1697-704.
14. Bradford PA. Extended-spectrum beta-lactamases in the 21 st century: Characterisation, Epidemiology, and detection of this important resistant threat. Clin Microbiol Rev 2001;14:933-51. (Pubitemid 32979636)
15. Sanders WE, Sanders CC. Cycling of antibiotics: An approach to circumvent resistance in specialized units of the hospital. Clin Microbiol Infect 1996;1:223-5.